Company Overview

Development Stage

About the Company

[Summary] A pioneer in precision oncology medicine

Founded in April 2015, Gene+ Technology has established multiple entities including medical testing laboratories, gene research institutes, and medical device industrialization bases in Beijing, Suzhou, and Shenzhen, with over 1,000 employees and an operating area of more than 14,000 square meters. Focusing on precision oncology, the company leverages next-generation sequencing (NGS) testing and a tumor gene big data platform to cover the entire chain of tumor prevention and treatment, building four major business segments: clinical testing services, medical device manufacturing, technology cooperation services, and tumor prevention and treatment services. It is committed to becoming the most trusted tumor gene big data service platform.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Gene+ Financing History (10 rounds)

Manage
D轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 3亿人民币
  • Investor: 盛世投资,昌发展

Gene+ How Fast Is Hiring Growing? (69 open positions)

Manage
Note: How fast is hiring at Beijing Gene+ Technology Co., Ltd. growing? Gene+2025: 89 openings (down 6%), 2024: 95 openings (down 62%), 2023: 253 openings (down 29%), 2022: 357 openings (up 11%), 2021: 323 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Gene+ Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 44%
  • 2024: Down 80%
  • 2023: Down 19%
  • 2022: Up 38%
Gene+ Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Beijing Gene+ Technology Co., Ltd. growing? Gene+Master's recruitment over the years: 2025: 23 openings (up 44%), 2024: 16 openings (down 80%), 2023: 79 openings (down 19%), 2022: 98 openings (up 38%), 2021: 71 openings.

Gene+ Doctoral Degree Job Demand Analysis

(More)
+100%
Growth Rate
2026 vs 2025
Gene+ Doctoral Hiring by Year: 2026 — 1 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Beijing Gene+ Technology Co., Ltd. growing? Gene+Doctorate recruitment over the years: 2026: 2 openings (up 226%), 2025: 1 openings (up 44%), 2023: 2 openings (down 19%), 2022: 4 openings (up 38%), 2021: 3 openings.

Gene+ R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Beijing Gene+ Technology Co., Ltd.? Based on an analysis of Gene+'s job postings over the past year, "科研类" demand: 18.8%, "生物/制药/化工/环保类": 13.8%, "医疗卫生/美容保健类": 12.8%, "计算机/网络/技术类": 12.8%, "其他(研发和技术类)": 6.4%. For reference only.

Gene+ — What Are the Salaries Like? (218 records)

Manage
salary range: 3K - 30K, 58.8% of roles pay ¥10-20K
Note: salary statistics are based on 218 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Beijing Gene+ Technology Co., Ltd.?Gene+58.8% of positions earn 10-20K, Fresh graduate salary: ¥8.9K。销售类 average salary ¥14.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Gene+

(More)
Are salaries high at Beijing Gene+ Technology Co., Ltd.? We provide: 销售,大客户,实习生,客户经理,管培生,市场,bd,产品经理,地区经理,临床,研发工程师,实验员,msl,行政,产品研发,运营,推广,生产工,生信工程师,项目经理. Click to view detailed salary analysis by job.

Gene+ honors, qualifications & industry associations

Gene+ Related Industry Tags

Job Category

  • 销售类
    49.1% of total 49.1%
  • 科研类
    18.8% of total 18.8%
  • 生物/制药/化工/环保类
    13.8% of total 13.8%
  • 经营管理类
    13.3% of total 13.3%

Education

  • 本科
    45.9% of total 45.9%
  • 硕士
    39% of total 39%
  • 不限
    8.7% of total 8.7%
  • 大专
    5% of total 5%

Experience

  • 3-5年
    32.6% of total 32.6%
  • 1-3年
    28% of total 28%
  • 5-10年
    13.8% of total 13.8%
  • 应届生
    13.3% of total 13.3%
View Detailed Analysis

What does Beijing Gene+ Technology Co., Ltd. require? Who is Gene+ hiring? Gene+ recruitment: 销售类占比最多占49.1%,其次是科研类占18.8%. What education can get in at Gene+? 本科占比最多占45.9%,其次是硕士占39%. High education required at Gene+? 硕士占39%,博士占1.4%. Work experience required at Gene+? 3-5年占比最多占32.6%,其次是1-3年占28%. Where are the job locations at Gene+? 北京占比最多占42.2%,其次是深圳占8.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 12,820.5035万(元)
Legal Representative: 易鑫
Date Established:
Credit Code: 91110114339725350Q
Registered Address: 北京市昌平区回龙观镇生命园路8号院一区6号-2至12层101(6号楼9层905)(昌平示范园)

Partners & Suppliers

吉因加为普瑞金提供肿瘤基因检测服务 Source
合作客户 基因检测
吉因加为百济神州提供基因检测服务支持临床试验 Source
合作客户 药企
吉因加与信达生物合作开发肿瘤药物伴随诊断 Source
合作客户 药企
吉因加为君实生物的PD-1抑制剂提供伴随诊断基因检测服务 Source
合作客户 药企
吉因加为默沙东提供基因检测服务支持临床试验 Source
合作客户 药企

People who follow Gene+ also follow

Gene+ Competitors (Similar Companies)

精准医疗 肿瘤精准医疗 NGS 临床检测
“Gene technology benefits humanity”
“Products for the diagnosis and treatment of allergic diseases”
中间体 生产 原料药 中间体生产
“Committed to the development of the pharmaceutical industry and human ”
“Biological diagnostic reagents and pharmaceuticals”
制药/药业 基因工程 凝胶 医药
“创造更多高效、优质,低价的生物大分子药物”
卫生服务中心 医疗服务 医学检验 医学影像
模式识别 生命科学 纳米材料 成像系统
“Adhering to the corporate culture of science and excellence, committed”
“一家拥有70余年辉煌历史的制药企业”
“连续多年位居国内皮肤临床用药领导地位”
卫生服务中心 医疗护理 眼科 美容
“Large-scale pharmaceutical distribution enterprise”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates